Well I believe you have my vote for post of the year. Congratulations!!!
Great science but horrible business management. All lab tests great with zero failures. Great science
A company that went public with 50M shares and a 20M float was an absolute gem. The toxic raising of funds especially with regard to the convertibles has made sure that only the few will really benefit should the science still pan out. By fair estimates between common, preferred, convertibles and bonus shares Regen will most likely end up with around 1.5B Shares (maybe more)
Not sure where Mr Koos got his business degree but I doubt that will make his Alma Mater proud.
News 
Market Data 
Discover 
